All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99
Paper Submission

Why Us? >>
- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More...
- Search engine friendly

Biologics: Targets and Therapy

ISSN Print: 1177-5475

ISSN Online:

Website: https://www.dovepress.com/biologics-targets-and-therapy-journal

Share:




Go

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F

Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma

Walsh GM

Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib

Nooka A, Gleason C, Casbourne D, Lonial S

Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer

D'Arcangelo M, Cappuzzo F

Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

Cantini F, Niccoli L, Cassara E, Kaloudi O, Nannini C

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents

Ververis K, Hiong A, Karagiannis TC, Licciardi PV

Treatment of hemophilia B: focus on recombinant factor IX

Franchini M, Frattini F, Crestani S, Sissa C, Bonfanti C

Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma

Ansari J, Hussain SA, Ansari A, Glaholm J

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents

Ververis K,Hiong A,Karagiannis TC,Licciardi PV

Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma

Ansari J,Hussain SA,Ansari A,Glaholm J

Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer

D'Arcangelo M,Cappuzzo F

Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma

Walsh GM

Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib

Nooka A,Gleason C,Casbourne D,Lonial S

Clinical use of crizotinib for the treatment of non-small cell lung cancer

Roberts PJ

Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

Cantini F,Niccoli L,Cassara E,Kaloudi O

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

Benucci M,Saviola G,Manfredi M,Sarzi-Puttini P

Treatment of hemophilia B: focus on recombinant factor IX

Franchini M,Frattini F,Crestani S,Sissa C

Cetuximab: its unique place in head and neck cancer treatment

Specenier P,Vermorken JB

Clinical use of biologics in vasculitis syndromes

Paroli M

Castration-resistant prostate cancer: potential targets and therapies

Parray A, Siddique HR, Nanda S, Konety BR, Saleem M

First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors

Nguyen KS, Neal JW

Emerging role of multikinase inhibitors for refractory thyroid cancer

Perez CA, Arango BA, Velez M, Raez LE, Santos ES

Hepatocellular carcinoma: natural history, current management, and emerging tools

Tinkle CL, Haas-Kogan D

OnabotulinumtoxinA in the treatment of neurogenic bladder

Gulamhusein A, Mangera A

Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases

Kobrynski L

Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) – a review of a new treatment paradigm

Heslet L, Nielsen JD, Nepper-Christensen S

Efficacy of infliximab in refractory Beh et’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E, Susini M, Lenzetti I

Eribulin mesylate in the treatment of metastatic breast cancer

Jain S, Cigler T

Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70

Orme ME, MacGilchrist KS, Mitchell S, Spurden D, Bird A

Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update

Wojciechowski D, Vincenti F

Natural killer cells: role in local tumor growth and metastasis

Langers I, Renoux VM, Thiry M, Delvenne P, Jacobs N

Cetuximab and biomarkers in non-small-cell lung carcinoma

Patil N, Abba M, Allgayer H

Lebrikizumab in the personalized management of asthma

Thomson NC, Patel M, Smith AD

The effect of erythropoietin on normal and neoplastic cells

Elliott S, Sinclair AM

Role of CD44 as a marker of cancer stem cells in head and neck cancer

Trapasso S, Allegra E

Ovarian cancer: emerging molecular-targeted therapies

Sourbier C

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure

Kekow J, Mueller-Ladner U, Schulze-Koops H

Significant neutralizing activities against H2N2 influenza A viruses in human intravenous immunoglobulin lots manufactured from 1993 to 2010

Kubota-Koketsu R, Yunoki M, Okuno Y, Ikuta K

B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms

Wilson HL

Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?

Jones G, Darian-Smith E, Kwok M, Winzenberg T

Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

Cantini F, Niccoli L, Cassarà E, Kaloudi O, Nannini C

Monoclonal antibodies and Fc fragments for treating solid tumors

Eisenbeis AM, Grau SJ

Pediatric ulcerative colitis: current treatment approaches including role of infliximab

Bradley GM, Oliva-Hemker M

Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection

Ippoliti G, D'Armini AM, Lucioni M, Marjieh M, Viganò M

Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis

Hasan E, Olusi S, Al-Awadhi A, Mokaddem K, Sharma P, George S

Role of vandetanib in the management of medullary thyroid cancer

Brassard M, Rondeau G

New developments in the management of hepatitis C virus infection: focus on boceprevir

Berenguer M, López-Labrador FX

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis

Thorlund K, Druyts E, Avi a-Zubieta JA, Mills EJ

Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease

Kapoor S

Clofilium inhibits Slick and Slack potassium channels

Tejada MA, Stolpe K, Meinild AK, Klaerke DA

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705